- 17-Hydroxypregnenolone
drugbox
IUPAC_name = 3β,17-dihydroxypregn-5-en-20-one
CAS_number = 387-79-1
ATC_prefix =
ATC_suffix =
PubChem = 3032570
DrugBank =
C = 21 | H = 32 | O = 3
molecular_weight = 332.48 g/mol
bioavailability =
protein_bound =
metabolism =Adrenal Gonad s
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_UK =
legal_US =
legal_status =
routes_of_administration =
melting_point = 26817-Hydroxypregnenolone (also 17-OH-pregnenolone and 17α-hydroxypregnenolone), is a C21
steroid that is obtained byhydroxylation ofpregnenolone at the C17α position. This step is performed by themitochondria l cytochrome P450 enzyme 17α-hydroxylase (CYP17A1 ) that is present in theadrenal andgonad s. Peak levels are reached in humans at the end ofpuberty and then decline. [Hill M, Lukac D, Lapcik O, Sulcova J, Hampl R, Pouzar V, Starka L. Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects. Clin Chem Lab Med. 1999 Apr;37(4):439-47. PMID 10369116] High levels are also achieved duringpregnancy .Prohormone
17-OH-pregnenolone is considered a
prohormone in the formation ofdehydroepiandrosterone (DHEA), itself a prohomone of thesex steroid s.This conversion is mediated by the enzyme 17,20 lyase . As such 17-OH-pregenolone represents an intermediary in the delta-5-pathway that leads from pregnenolone to DHEA. 17-hydroxypregneolone is also converted to
17-hydroxyprogesterone , a prohomone forglucocorticosteroid s andandrostenedione through the activity of 3-hydroxysteroid dehydrogenase.Neurohormone
There is some evidence that 17-OH-pregnenolone may have activity as a
neurohormone . [Matsunaga M, Ukena K, Baulieu EE, Tsutsui K7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc Natl Acad Sci USA 2004 Dec 7;101(49):17282-7. PMID 15569930]Clinical use
Measurements of 17-OH-pregnenolone are useful in the diagnosis of certain forms of
congenital adrenal hyperplasia . [Riepe FG, Mahler P, Sippell, Partsch CJ. Longitudinal Study of Plasma Pregnenolone and 17-Hydroxypregnenolone in Full-Term and Preterm Neonates at Birth and during the Early Neonatal Period. The Journal of Clinical Endocrinology & Metabolism (2002) 87: 4301-4306 [http://jcem.endojournals.org/cgi/content/full/87/9/4301] ] In patients withcongenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency 17-OH-pregnenolone is increased, while in patients withcongenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency levels are low to absent.ee also
Congenital adrenal hyperplasia
=AdditionalReferences
Wikimedia Foundation. 2010.